Home > Healthcare > Pharmaceuticals > Finished Drug Form > Spine Biologics Market
Spine Biologics Market Size
- Report ID: GMI6096
- Published Date: Jun 2023
- Report Format: PDF
Spine Biologics Market Size
Spine Biologics Market size in 2022 was valued at USD 2.2 billion in 2022 and is expected to witness CAGR of 4.3% by 2032 owing to increasing prevalence of spine deformities, growing awareness and patient preference for minimally invasive procedures, and technological advancements.
Spine biologics refer to a type of medical treatments or therapies that are developed by using biological materials or substances for treating various spinal conditions and disorders. They are used as alternatives to traditional surgical techniques, and provide biological support by promoting bone healing, fusion, and regeneration of the spine. They facilitate in reducing pain, improve functioning and better quality of life.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Spine Biologics Market Size in 2022: | USD 2.2 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 4.3% |
| 2032 Value Projection: | USD 3.4 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 195 |
| Tables, Charts & Figures: | 340 |
| Segments covered: | Product, Surgery Type, End-user, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Spine Biologics Market Scope
